Accepted Manuscript Approaches Towards the Development of Chimeric DPP4/ACE Inhibitors for Treating Metabolic Syndrome Jitendra A. Sattigeri, Sachin Sethi, Joseph A. Davis, Shahadat Ahmed, Geeta V. Rayasam, Balasaheb G. Jadhav, Satya M Chilla, Dhrubajyoti Datta, A. Gadhave, Vamshi K. Tulasi, Tarun Jain, Sreedhara Voleti, Biju Benjamin, Sunitha Udupa, Garima Jain, Yogender Singh, Kona Srinivas, Vinay S. Bansal, Abhijit Ray, Pradip K. Bhatnagar, Ian A. Cliffe PII: S0960-894X(17)30415-8 DOI: http://dx.doi.org/10.1016/j.bmcl.2017.04.036 Reference: BMCL 24889 To appear in: Bioorganic & Medicinal Chemistry Letters Received Date: 23 January 2017 Revised Date: 24 March 2017 Accepted Date: 12 April 2017 Please cite this article as: Sattigeri, J.A., Sethi, S., Davis, J.A., Ahmed, S., Rayasam, G.V., Jadhav, B.G., Chilla, S.M., Datta, D., Gadhave, A., Tulasi, V.K., Jain, T., Voleti, S., Benjamin, B., Udupa, S., Jain, G., Singh, Y., Srinivas, K., Bansal, V.S., Ray, A., Bhatnagar, P.K., Cliffe, I.A., Approaches Towards the Development of Chimeric DPP4/ ACE Inhibitors for Treating Metabolic Syndrome, Bioorganic & Medicinal Chemistry Letters (2017), doi: http:// dx.doi.org/10.1016/j.bmcl.2017.04.036 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.